Association between psoriasis and chronic obstructive pulmonary disease: A systematic review and meta-analysis

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Li, Xin ^a,b   Kong, Lingjun ^a   Li, Fulun ^a   Chen, Chen ^b   Xu, Rong ^a   Wang, Hongshen ^b   Peng, Shiguang ^b   Zhou, Min ^a   Li, Bin ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; HIGH RISK POPULATION; HUMAN; MORTALITY; OBSERVATIONAL STUDY; PREVENTIVE MEDICINE; PSORIASIS; RISK REDUCTION; SMOKING CESSATION; SYSTEMATIC REVIEW; ADULT; AGED; COMPLICATION; META ANALYSIS; MIDDLE AGED; ODDS RATIO; RISK ASSESSMENT; SMOKING;

ADULT; AGED; HUMANS; MIDDLE AGED; OBSERVATIONAL STUDIES AS TOPIC; ODDS RATIO; PSORIASIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; SMOKING;

EID: 84956915533     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0145221     Document Type: Article

References (41)

1. Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. Journal of the American Academy of Dermatology. 2009; 60 (2):218-24. PMID: 19022533. doi:10.1016/j.jaad.2008.09.022.
2. Globe D, Bayliss MS, Harrison DJ. The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groups. Health and quality of life outcomes. 2009; 7:62. PMID: 19580674. doi:10.1186/1477-7525-7-62.
3. Liu Y, Krueger JG, Bowcock AM. Psoriasis: genetic associations and immune system changes. Genes and immunity. 2007; 8(1):1-12. PMID: 17093502.
4. Davidson A, Diamond B. Autoimmune diseases. The New England journal of medicine. 2001; 345 (5):340-50. PMID: 11484692.
5. Williams JP, Meyers JA. Immune-mediated inflammatory disorders (I.M.I.D.s): The economic and clinical costs. The American journal of managed care. 2002; 8(21 Suppl):S664-81; quiz S82-5. PMID: 12516953.
6. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American journal of respiratory and critical care medicine. 2007; 176(6):532-55. PMID: 17507545.
7. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. The New England journal of medicine. 2008; 359(22):2355-65. PMID: 19038881. doi:10.1056/NEJMra0800353.
8. Fletcher C, Peto R. The natural history of chronic airflow obstruction. British medical journal. 1977; 1 (6077):1645-8. PMID: 871704.
9. Tuder RM, Petrache I. Pathogenesis of chronic obstructive pulmonary disease. The Journal of Clinical Investigation. 2012; 122(8):2749-55. PMC3408733. doi:10.1172/JCI60324 PMID: 22850885.
10. MacNee W. Oxidants/antioxidants and chronic obstructive pulmonary disease: pathogenesis to therapy. Novartis Foundation symposium. 2001; 234:169-85; discussion 85-8. PMID: 11199095.
11. Chiang YY, Lin HW. Association between psoriasis and chronic obstructive pulmonary disease: A population- based study in Taiwan. Journal of the European Academy of Dermatology and Venereology: JEADV. 2012; 26(1):59-65. PMID: 21388457. doi:10.1111/j.1468-3083.2011.04009.x.
12. Al-Mutairi N, Al-Farag S, Al-Mutairi A, Al-Shiltawy M. Comorbidities associated with psoriasis: An experience from the Middle East. The Journal of dermatology. 2010; 37(2):146-55. PMID: 20175849. doi:10.1111/j.1346-8138.2009.00777.x.
13. Wakkee M, de Vries E, van den Haak P, Nijsten T. Increased risk of infectious disease requiring hospitalization among patients with psoriasis: A population-based cohort. Journal of the American Academy of Dermatology. 2011; 65(6):1135-44. 10.1016/j.doi:10.1016/j.jaad.2010.08.036PMID: 21664719.
14. Dreiher J, Weitzman D, Shapiro J, Davidovici B, Cohen AD. Psoriasis and chronic obstructive pulmonary disease: A case-control study. The British journal of dermatology. 2008; 159(4):956-60. PMID: 18637897. doi:10.1111/j.1365-2133.2008.08749.x.
15. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European journal of epidemiology. 2010; 25(9):603-5. PMID: 20652370. doi:10.1007/s10654-010-9491-z.
16. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama. 2000; 283(15):2008-12. PMID: 10789670.
17. Pearce DJ, Morrison AE, Higgins KB, Crane MM, Balkrishnan R, Fleischer AB Jr., et al. The comorbid state of psoriasis patients in a university dermatology practice. The Journal of dermatological treatment. 2005; 16(5-6):319-23. PMID: 16428152.
18. Robinson D Jr, Hackett M, Wong J, Kimball AB, Cohen R, Bala M. Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: An exploration using US healthcare claims data, 2001-2002. Current medical research and opinion. 2006; 22(5):989-1000. PMID: 16709321.
19. Nestle FO, Kaplan DH, Barker J. Psoriasis. The New England journal of medicine. 2009; 361(5):496- 509. PMID: 19641206. doi: 10.1056/NEJMra0804595.
20. Eurlings IM, Dentener MA, Mercken EM, de Cabo R, Bracke KR, Vernooy JH, et al. A comparative study of matrix remodeling in chronic models for COPD; mechanistic insights into the role of TNFalpha. American journal of physiology Lung cellular and molecular physiology. 2014; 307(7):L557-65. PMID: 25106431. doi:10.1152/ajplung.00116.2014.
21. Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. The European respiratory journal. 2008; 31(6):1334-56. PMID: 18515558. doi:10.1183/09031936.00018908.
22. Lapperre TS, Postma DS, Gosman MM, Snoeck-Stroband JB, ten Hacken NH, Hiemstra PS, et al. Relation between duration of smoking cessation and bronchial inflammation in COPD. Thorax. 2006; 61(2):115-21. PMID: 16055612.
23. Wiczling P, Rosenzweig M, Vaickus L, Jusko WJ. Pharmacokinetics and pharmacodynamics of a chimeric/humanized anti-CD3 monoclonal antibody, otelixizumab (TRX4), in subjects with psoriasis and with type 1 diabetes mellitus. Journal of clinical pharmacology. 2010; 50(5):494-506. PMID: 19934031. doi:10.1177/0091270009349376.
24. Jin Y, Wan Y, Chen G, Chen L, Zhang MQ, Deng L, et al. Treg/IL-17 ratio and Treg differentiation in patients with COPD. PloS one. 2014; 9(10):e111044. PMID: 25329073. doi:10.1371/journal.pone.0111044.
25. Hijnen D, Knol EF, Gent YY, Giovannone B, Beijn SJ, Kupper TS, et al. CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-gamma, IL-13, IL-17, and IL-22. The Journal of investigative dermatology. 2013; 133(4):973-9. PMID: 23223131. doi:10.1038/jid.2012.456.
26. Huang N, Liu L, Wang XZ, Liu D, Yin SY, Yang XD. Association of interleukin (IL)-12 and IL-27 gene polymorphisms with chronic obstructive pulmonary disease in a Chinese population. DNA and cell biology. 2008; 27(9):527-31. PMID: 18554158. doi:10.1089/dna.2007.0715.
27. Zhang L, Cheng Z, Liu W, Wu K. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients. Copd. 2013; 10(4):459-65. PMID: 23537276. doi:10.3109/15412555.2013.770456.
28. Flisiak I, Zaniewski P, Chodynicka B. Plasma TGF-beta1, TIMP-1, MMP-1 and IL-18 as a combined biomarker of psoriasis activity. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals. 2008; 13(5):549-56. PMID: 18979644.
29. Kondo S, Yoneta A, Yazawa H, Kamada A, Jimbow K. Downregulation of CXCR-2 but not CXCR-1 expression by human keratinocytes by UVB. Journal of cellular physiology. 2000; 182(3):366-70. PMID: 10653603.
30. Dowlatshahi EA, van der Voort EA, Arends LR, Nijsten T. Markers of systemic inflammation in psoriasis: A systematic review and meta-analysis. The British journal of dermatology. 2013; 169(2):266-82. PMID: 23550658. doi:10.1111/bjd.12355.
31. Singh K, Gatzka M, Peters T, Borkner L, Hainzl A, Wang H, et al. Reduced CD18 levels drive regulatory T cell conversion into Th17 cells in the CD18hypo PL/J mouse model of psoriasis. Journal of immunology (Baltimore, Md: 1950). 2013; 190(6):2544-53. PMID: 23418628.
32. Starodubtseva NL, Sobolev VV, Soboleva AG, Nikolaev AA, Bruskin SA. [Expression of genes for metalloproteinases (MMP-1, MMP-2, MMP-9, and MMP-12) associated with psoriasis]. Genetika. 2011; 47(9):1254-61. Epub 2011/11/29. PMID: 22117411.
33. Ludolph-Hauser D, Schubert C, Wiedow O. Structural changes of human epidermis induced by human leukocyte-derived proteases. Experimental dermatology. 1999; 8(1):46-52. PMID: 10206721.
34. Tabrizi M, Wang B, Lu H, Huang S, Bell G, Schwab G, et al. Population pharmacokinetic evaluation of a fully human IgG monoclonal antibody in patients with inflammatory diseases. Inflammation & allergy drug targets. 2010; 9(4):229-37. PMID: 20860546.
35. Terricabras E, Benjamim C, Godessart N. Drug discovery and chemokine receptor antagonists: eppur si muove! Autoimmunity Reviews. 2004; 3(7-8):550-6. doi:10.1016/j.autrev.2004.07.037 PMID: 15546804.
36. Wittmann M, Helliwell PS. Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases. Dermatology and therapy. 2013; 3(1):1-15. PMID: 23888251. doi:10.1007/s13555-013-0023-0.
37. Huang Z, Mancini JA. Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD. Current medicinal chemistry. 2006; 13(27):3253-62. PMID: 17168849.
38. Kristensen SL, McInnes IB, Sattar N. Psoriasis, psoriatic arthritis and cardiovascular risk: Are we closer to a clinical recommendation? Annals of the rheumatic diseases. 2015; 74(2):321-2. PMID: 25429028. doi:10.1136/annrheumdis-2014-206617.
39. Armstrong AW, Harskamp CT, Dhillon JS, Armstrong EJ. Psoriasis and smoking: A systematic review and meta-analysis. The British journal of dermatology. 2014; 170(2):304-14. PMID: 24117435. doi:10.1111/bjd.12670.
40. Egger M, Smith GD. Bias in location and selection of studies. BMJ (Clinical research ed). 1998; 316 (7124):61-6. PMID: 9451274.
41. Martin A, Badrick E, Mathur R, Hull S. Effect of ethnicity on the prevalence, severity, and management of COPD in general practice. The British journal of general practice: The journal of the Royal College of General Practitioners. 2012; 62(595):e76-e81. PMID: 22520773.